Literature DB >> 17376588

New treatment strategies in the management of hormone refractory prostate cancer (HRPC): only chemotherapy?

Alessandro Sciarra, Stefano Salciccia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17376588     DOI： 10.1016/j.eururo.2007.03.029

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.

Authors:  Liangyou Wang; Daniel T Sloper; Sadiya N Addo; Defeng Tian; Joel W Slaton; Chengguo Xing
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.